EUVIMEDEUVIMED entdecken
Open Access

Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin‐Fixed Paraffin‐Embedded Tissue

Stefanie K Schwab, Peter S Harris, Cole Michel, Courtney D McGinnis, Rooban B Nahomi, Mohammed A Assiri, Richard Reisdorph, Kammi Henriksen, David J Orlicky iD, Moshe Levi, Avi Rosenberg, Ram H Nagaraj und 1 weitere

PROTEOMICS – Clinical Applications · 2024

DOI: 10.1002/prca.202400018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2024. Verfasst von Stefanie K Schwab und 12 weiteren Autor:innen. Beteiligte Einrichtung: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Paraffin Embedding, Formaldehyde. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAAA NIH HHS, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Diabetic kidney disease (DKD) is a serious complication of diabetes mellitus and a leading cause of chronic kidney disease and end‐stage renal disease. One potential mechanism underlying cellular dysfunction contributing to kidney disease is aberrant protein post‐translational modifications. Lysine acetylation is associated with cellular metabolic flux and is thought to be altered in patients with diabetes and dysfunctional renal metabolism. Experimental Design A novel extraction and LC‐MS/MS approach was adapted to quantify sites of lysine acetylation from formalin‐fixed paraffin‐embedded (FFPE) kidney tissue and from patients with DKD and non‐diabetic donors ( n = 5 and n = 7, respectively).

Results

Analysis of FFPE tissues identified 840 total proteins, with 225 of those significantly changing in patients with DKD. Acetylomic analysis quantified 289 acetylated peptides, with 69 of those significantly changing. Pathways impacted in DKD patients revealed numerous metabolic pathways, specifically mitochondrial function, oxidative phosphorylation, and sirtuin signaling. Differential protein acetylation in DKD patients impacted sirtuin signaling, valine, leucine, and isoleucine degradation, lactate metabolism, oxidative phosphorylation, and ketogenesis. Conclusions and Clinical Relevance A quantitative acetylomics platform was developed for protein biomarker discovery in formalin‐fixed and paraffin‐embedded biopsies of kidney transplant patients suffering from DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesParaffin EmbeddingFormaldehydeHumansAcetylationTandem Mass SpectrometryMaleProteomicsFemaleProtein Processing, Post-TranslationalTissue FixationLysineMiddle AgedKidneyChromatography, Liquid

Stichwörter der Autor:innen

acetylationdiabetesformalin‐fixed paraffin‐embeddedkidney diseaseproteomics

Substanzen

FormaldehydeLysine

Autor:innen und Institutionen

  • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Sue Anschutz-Rodgers Eye Center and Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Department of Pathology, University of Chicago Medical Center, Chicago, Illinois, USA.
  • Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, District of Columbia, USA.

ORCID-Profile: David J Orlicky, Kristofer S Fritz

Förderung

  • NCATS NIH HHS
  • NIAAA NIH HHS
  • NEI NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • National Eye Institute
  • National Center for Advancing Translational Sciences

Zitieren

APA

Schwab, S. K., Harris, P. S., Michel, C., McGinnis, C. D., Nahomi, R. B., Assiri, M. A., Reisdorph, R., Henriksen, K., Orlicky, D. J., Levi, M., Rosenberg, A., Nagaraj, R. H., & Fritz, K. S. (2024). Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin‐Fixed Paraffin‐Embedded Tissue. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202400018

Vancouver

Schwab SK, Harris PS, Michel C, McGinnis CD, Nahomi RB, Assiri MA, et al. Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin‐Fixed Paraffin‐Embedded Tissue. PROTEOMICS – Clinical Applications. 2024. doi:10.1002/prca.202400018

BibTeX
@article{Schwab2024,
  author = {Schwab, Stefanie K and Harris, Peter S and Michel, Cole and McGinnis, Courtney D and Nahomi, Rooban B and Assiri, Mohammed A and Reisdorph, Richard and Henriksen, Kammi and Orlicky, David J and Levi, Moshe and Rosenberg, Avi and Nagaraj, Ram H and Fritz, Kristofer S},
  title = {Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin‐Fixed Paraffin‐Embedded Tissue},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2024},
  doi = {10.1002/prca.202400018}
}
Kostenlos starten →